TriSalus Life Sciences (TLSI) Payables (2022 - 2025)
Historic Payables for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $3.8 million.
- TriSalus Life Sciences' Payables rose 16168.74% to $3.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.8 million, marking a year-over-year increase of 16168.74%. This contributed to the annual value of $2.3 million for FY2024, which is 3294.01% down from last year.
- TriSalus Life Sciences' Payables amounted to $3.8 million in Q3 2025, which was up 16168.74% from $1.9 million recorded in Q2 2025.
- TriSalus Life Sciences' 5-year Payables high stood at $5.9 million for Q4 2022, and its period low was $1.4 million during Q3 2024.
- Its 4-year average for Payables is $2.7 million, with a median of $2.3 million in 2024.
- Per our database at Business Quant, TriSalus Life Sciences' Payables plummeted by 5343.43% in 2024 and then soared by 16168.74% in 2025.
- Quarter analysis of 4 years shows TriSalus Life Sciences' Payables stood at $5.9 million in 2022, then tumbled by 42.44% to $3.4 million in 2023, then tumbled by 32.94% to $2.3 million in 2024, then soared by 66.4% to $3.8 million in 2025.
- Its last three reported values are $3.8 million in Q3 2025, $1.9 million for Q2 2025, and $2.8 million during Q1 2025.